Dr. Vicky Yamamoto is a cancer scientist at Keck School of Medicine of USC. Prior to joining USC, Dr. Yamamoto has worked at Mount St. Mary’s University, The Scripps Research Institute, the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, and California Institute of Technology. She has publications in major journals, including Cell, Developmental Cell, Cell Reports, PlosOne, the Journal of Alzheimer’s Disease, NeuroImage, and Oral Oncology and has written several book chapters. Dr. Yamamoto’s current research and expertise are in developmental neurobiology, cell signal transduction, cancer stem cells, molecular targeted therapy, screening and identification of small molecules for cancer treatment, establishment of tissue bank, and clinical trials. She hopes to bring a wealth of knowledge and expertise in the field of biomedical sciences to the advisory board and hopes to achieve the goal of helping clinicians determine the most effective and precise treatment for cancer patients.
Dr. Yamamoto is one of the founding members of Society for Brain Mapping & Therapeutics (SBMT), which was established in 2003. She has been serving as a member of the Board of Directors of SBMT and the Brain Mapping Foundation since 2007. She has served on many committees including publication committee as a member of the editorial board and co-chaired the industry committee of SBMT where she provided a liaison with near 3,000 industry partners of the society. She is currently serving as an Executive Director for SBMT since 2017.
Dr. Yamamoto holds other leadership roles in a number of organizations, currently serving as a Chair of the Board of Directors of Hand-in-Hand Community Health Clinic and a Chair of the Scientific Advisory Board of Blue Horizon International.
Dr. Yamamoto received undergraduate degrees, BS in Biological Sciences and BA in Chemistry, from Mount St. Mary’s University and a doctorate degree from Keck School of Medicine of University of Southern California.